Y-Intercept (HK)’s Vir Biotechnology VIR Stock Holding History

Y-Intercept (HK)’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.62M	Sell	144,722 -69,807	-33%	-$698K	0.04%	738
2026 Q2	$2.19M	Buy	214,529 +79,982	+59%	+$761K	0.04%	648
2026 Q1	$1.21M	Buy	+134,547	New	+$1.07M	0.02%	945
2025 Q2	–	Sell	-26,073	Closed	-$169K	–	2051
2025 Q1	$169K	Buy	+26,073	New	+$232K	0.01%	1077
2024 Q4	–	Sell	-22,455	Closed	-$168K	–	1691
2024 Q3	$168K	Sell	22,455 -81,494	-78%	-$708K	0.01%	1187
2024 Q2	$925K	Buy	103,949 +85,629	+467%	+$821K	0.05%	525
2024 Q1	$186K	Buy	+18,320	New	+$187K	0.01%	1176
2023 Q4	–	Sell	-42,266	Closed	-$396K	–	1675
2023 Q3	$396K	Buy	+42,266	New	+$603K	0.04%	651
2023 Q2	–	Sell	-38,473	Closed	-$895K	–	1752
2023 Q1	$895K	Buy	38,473 +3,836	+11%	+$98.1K	0.1%	289
2022 Q4	$877K	Buy	+34,637	New	+$849K	0.13%	241
2022 Q3	–	Sell	-12,354	Closed	-$315K	–	1290
2022 Q2	$315K	Buy	+12,354	New	+$288K	0.04%	566

Other funds holding VIR

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Foster Group West Des Moines, Iowa $3.68B AUM 13.84% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Y-Intercept (HK)'s VIR Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Vir Biotechnology (VIR) stake by 33% in Q3 2026, selling an estimated $698K and leaving 144,722 shares worth $1.62M. The position accounts for 0.04% of the portfolio, ranked #738.

Y-Intercept (HK) first reported a position in VIR in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.19M in Q2 2026. 31 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

Y-Intercept (HK) held 144,722 shares of Vir Biotechnology worth $1.62M as of Q3 2026.
Y-Intercept (HK) sold 69,807 Vir Biotechnology shares in Q3 2026, an estimated $698K.
Vir Biotechnology made up 0.04% of Y-Intercept (HK)'s portfolio in Q3 2026, its #738 holding.
Y-Intercept (HK) first reported a position in Vir Biotechnology in Q2 2022 and has held it in 11 quarters since.
Y-Intercept (HK)'s Vir Biotechnology position peaked at $2.19M in Q2 2026.
31 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.